FOI Ref: 0192FOI1920

29^th January 2020 

Freedom of Information Act 2000 – Request for Information

We are pleased to respond to your request for information and our response is set out below:

Request /Response

I am writing to you today to formally request the following information about services relating to glucagon-like peptide-1 receptor agonists (GLP-1 RA) (https://www.diabetes.org.uk/guide-to-diabetes/managing-your-diabetes/treating-your-diabetes/tablets-and-medication/incretin-mimetics, also see BNF Chapter 6).

1. Does NHS Sheffield CCG have any local commissioned services/Locally enhanced services in primary care for GLP1 RA?

No

• If yes, please could you provide and attach a copy of the service specification for this service(s)? 

If the service specification is already in the public domain, then please provide a direct web link to this document.

 

• If yes to having a service in place, is this service commissioned “per patient initiated”? Yes/No
• If yes, what cost band does this fit into?  Please answer using provided banding below.

<£50/ £50-£75 / £75-£100 / £100-£125 / £125-£150 / £150-£175 / £175-£200 / >£200

2. Does NHS Sheffield CCG have any current (2019/20) primary care pharmaceutical rebate schemes in place for GLP1 RA?

No 

• If yes- please provide details of this/these scheme(s) as per the table below:

Name of primary care pharmaceutical rebate scheme(s) for GLP1 RA.	Name of Drug(s) covered	Companies involved in the scheme

If details already exist within public domain, then please provide a direct web link to this/these document(s).

3. Does NHS Sheffield CCG have any current primary care prescribing incentive scheme(s) (2019/20) for GLP1 RA?

No 

• If yes- please provide details of this/these scheme(s) as per the table below:

If details already exist within public domain, then please provide a direct web link to this/these document(s) 

• If yes, does the incentive scheme require or link to any GLP1 RA audits? Yes/No (Please capture in the table below). 

Name of primary care prescribing incentive scheme(s) (2019/20) for GLP1 RA	Name of Drug(s) covered	Requires GLP1 RA Audits Y/N